Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Hayward

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Healthcarepapers|December 15, 2006
Networks: better language requiredSarah Hayward
Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees|August 19, 2007
Who reviews the projects of unaffiliated researchers for ethics? A case study from AlbertaMaeve O'Beirne, Michael Stingl, Sarah Hayward
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2026
Corrigendum to 'Avutometinib and defactinib: a novel dual pathway inhibition strategy for recurrent KRAS-mutant low-grade serous ovarian cancer' [International Journal of Gynecological Cancer Volume 36 Issue 5 (2026) 104635]Sarah Hayward, Cassidy Blaiss, Erin Hickey Zacholski, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 18, 2026
Avutometinib and defactinib: a novel dual pathway inhibition strategy for recurrent KRAS-mutant low-grade serous ovarian cancerSarah Hayward, Cassidy Blaiss, Erin Hickey Zacholski, et al.
Healthcare Policy = Politiques De Sante|March 24, 2009
Innovations in the Ethical Review of Health-Related Quality Improvement and Research: The Alberta Research Ethics Community Consensus Initiative (ARECCI)Brad Hagen, Maeve O'Beirne, Sunil Desai, et al.
Comparative and Functional Genomics|July 17, 2008
Analysis of known bacterial protein vaccine antigens reveals biased physical properties and amino acid compositionCarl Mayers, Melanie Duffield, Sonya Rowe, et al.
Infection and Immunity|February 21, 2002
A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infectionHelen C Flick-Smith, Nicola J Walker, Paula Gibson, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Healthcarepapers|December 15, 2006
Networks: better language requiredSarah Hayward
Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees|August 19, 2007
Who reviews the projects of unaffiliated researchers for ethics? A case study from AlbertaMaeve O'Beirne, Michael Stingl, Sarah Hayward
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2026
Corrigendum to 'Avutometinib and defactinib: a novel dual pathway inhibition strategy for recurrent KRAS-mutant low-grade serous ovarian cancer' [International Journal of Gynecological Cancer Volume 36 Issue 5 (2026) 104635]Sarah Hayward, Cassidy Blaiss, Erin Hickey Zacholski, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 18, 2026
Avutometinib and defactinib: a novel dual pathway inhibition strategy for recurrent KRAS-mutant low-grade serous ovarian cancerSarah Hayward, Cassidy Blaiss, Erin Hickey Zacholski, et al.
Healthcare Policy = Politiques De Sante|March 24, 2009
Innovations in the Ethical Review of Health-Related Quality Improvement and Research: The Alberta Research Ethics Community Consensus Initiative (ARECCI)Brad Hagen, Maeve O'Beirne, Sunil Desai, et al.
Comparative and Functional Genomics|July 17, 2008
Analysis of known bacterial protein vaccine antigens reveals biased physical properties and amino acid compositionCarl Mayers, Melanie Duffield, Sonya Rowe, et al.
Infection and Immunity|February 21, 2002
A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infectionHelen C Flick-Smith, Nicola J Walker, Paula Gibson, et al.
Pageof 1